Bluefin Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,768
| Closed | -$261K | – | 331 |
|
|
2022
Q2 | $261K | Buy |
4,768
+48
| +1% | +$2.63K | 0.03% | 186 |
|
|
2022
Q1 | $257K | Sell |
4,720
-2,640
| -36% | -$144K | 0.02% | 209 |
|
|
2021
Q4 | $406K | Sell |
7,360
-736
| -9% | -$40.6K | 0.03% | 326 |
|
|
2021
Q3 | $387K | Buy |
+8,096
| New | +$387K | 0.04% | 270 |
|
|
2017
Q3 | – | Sell |
-11,277
| Closed | -$608K | – | 333 |
|
|
2017
Q2 | $608K | Buy |
11,277
+5,949
| +112% | +$321K | 0.07% | 176 |
|
|
2017
Q1 | $281K | Buy |
5,328
+311
| +6% | +$16.4K | 0.04% | 219 |
|
|
2016
Q4 | $241K | Buy |
+5,017
| New | +$241K | 0.01% | 249 |
|
|
2016
Q3 | – | Sell |
-4,870
| Closed | -$264K | – | 275 |
|
|
2016
Q2 | $264K | Buy |
+4,870
| New | +$264K | 0.03% | 209 |
|
|
2016
Q1 | – | Sell |
-39,803
| Closed | -$2.01M | – | 336 |
|
|
2015
Q4 | $2.01M | Buy |
+39,803
| New | +$2.01M | 0.16% | 117 |
|
|
2015
Q3 | – | Sell |
-5,186
| Closed | -$270K | – | 376 |
|
|
2015
Q2 | $270K | Buy |
5,186
+320
| +7% | +$16.7K | 0.02% | 289 |
|
|
2015
Q1 | $281K | Hold |
4,866
| – | – | 0.03% | 251 |
|
|
2014
Q4 | $260K | Buy |
4,866
+1,176
| +32% | +$62.8K | 0.02% | 336 |
|
|
2014
Q3 | $212K | Sell |
3,690
-138
| -4% | -$7.93K | 0.01% | 414 |
|
|
2014
Q2 | $300K | Buy |
3,828
+234
| +7% | +$18.3K | 0.01% | 380 |
|
|
2014
Q1 | $200K | Buy |
+3,594
| New | +$200K | 0.01% | 347 |
|